Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Jun 29, 2020 · 10-Q · 90 days after period end · 0001213900-20-016168
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$5.67M | -$5.67M | -$6.32M | -$8.06M |
| EPS Diluted | -$0.98 | -$0.05 | -$0.07 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed Jun 29, 2020 · 90 d after period end
